ConductScience.org, home

Paper20133865

Spatiotemporal controlled delivery of nanoparticles to injured vasculature.

Chan JM and 13 others. Proc Natl Acad Sci U S A, 2010. Cited by 178 papers, by iCite.

Cite this record

ConductScience Library. Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Papers, record 20133865. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20133865

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Spatiotemporal controlled delivery of nanoparticles to injured vasculature.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
178
iCite
Relative citation ratio, by iCite
4.76
iCite
Revised in PubMed
2024-09-04
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chan JMJuliana M
2Zhang LLiangfang
3Tong RRong
4Ghosh DDebuyati
5Gao WWeiwei
6Liao GGrace
7Yuet KPKai P
8Gray DDavid
9Rhee JWJune-Wha
10Cheng JJianjun
11Golomb GGershon
12Libby PPeter
13Langer RRobert
14Farokhzad OCOmid C

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood VesselsMajor topic
Drug Delivery SystemsMajor topic
NanoparticlesMajor topic
Amino Acid Sequence
Animals
Antigens
Biomedical Engineering
Cells, Cultured
Delayed-Action Preparations
Humans
Muscle, Smooth, Vascular
Nanomedicine
Paclitaxel
Peptide Library
Rats
Rats, Sprague-Dawley

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA119349NCI NIH HHSUnited StatesU54CA119349PubMed and NIHNIH RePORTER
K08 EB003647NIBIB NIH HHSUnited StatesK08EB003647PubMed and NIHNIH RePORTER
EB003647NIBIB NIH HHSUnited StatesK08EB003647PubMed and NIHNIH RePORTER
R21 CA139329NCI NIH HHSUnited StatesR21CA139329PubMed and NIHNIH RePORTER
U54 CA119349NCI NIH HHSUnited StatesU54CA119349PubMed and NIHNIH RePORTER

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115173077Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies.Clin Cancer Res2004https://conductscience.org/library/papers/15173077PubMed
212646012Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy.AAPS PharmSci2002https://conductscience.org/library/papers/12646012PubMed
311457057Polymerization of lactide with zinc and magnesium beta-diiminate complexes: stereocontrol and mechanism.J Am Chem Soc2001https://conductscience.org/library/papers/11457057PubMed
411848876Phage Display.Chem Rev1997https://conductscience.org/library/papers/11848876PubMed
511557668Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model.Arterioscler Thromb Vasc Biol2001https://conductscience.org/library/papers/11557668PubMed
617396134Angiogenesis: an organizing principle for drug discovery?Nat Rev Drug Discov2007https://conductscience.org/library/papers/17396134PubMed
78128245Biodegradable long-circulating polymeric nanospheres.Science1994https://conductscience.org/library/papers/8128245PubMed
819332089Extracellular matrix binding mixed micelles for drug delivery applications.J Control Release2009https://conductscience.org/library/papers/19332089PubMed
919525947Understanding biophysicochemical interactions at the nano-bio interface.Nat Mater2009https://conductscience.org/library/papers/19525947PubMed
1019805309Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19805309PubMed
1116670444Evaluation of a new polymer-coated paclitaxel-eluting stent for treatment of de novo lesions: six-month clinical and angiographic follow-up results of the APPLAUSE trial.J Invasive Cardiol2006https://conductscience.org/library/papers/16670444PubMed
1218654426Nanocarriers as an emerging platform for cancer therapy.Nat Nanotechnol2007https://conductscience.org/library/papers/18654426PubMed
1318672949Factors affecting the clearance and biodistribution of polymeric nanoparticles.Mol Pharm2008https://conductscience.org/library/papers/18672949PubMed
1418491339Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles.Angew Chem Int Ed Engl2008https://conductscience.org/library/papers/18491339PubMed
1519657379Alternative splicing and biological heterogeneity in prostate cancer.Nat Rev Urol2009https://conductscience.org/library/papers/19657379PubMed
1618758474Nanoparticle therapeutics: an emerging treatment modality for cancer.Nat Rev Drug Discov2008https://conductscience.org/library/papers/18758474PubMed
1718246072Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage.Nat Mater2008https://conductscience.org/library/papers/18246072PubMed
1817957183Nanoparticles in medicine: therapeutic applications and developments.Clin Pharmacol Ther2008https://conductscience.org/library/papers/17957183PubMed
198253711Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis.J Biol Chem1993https://conductscience.org/library/papers/8253711PubMed
2011452024Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements.Nucleic Acids Res2001https://conductscience.org/library/papers/11452024PubMed

See all 32 referencesDownload CSV of references

Cited by92

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 178 citations.

PMIDTitleJournalYearIn PapersSource
42948745Remodeling macrophage efferocytosis and phenotype via targeted nanoimmunotherapy for atherosclerosis.Acta Pharm Sin B2026https://conductscience.org/library/papers/42948745PubMed
42799491Tunable regional targeting of self-assembling peptide nanomaterials in acute myocardial infarction.Adv Nanobiomed Res2026https://conductscience.org/library/papers/42799491PubMed
41634764Macrophage pyroptosis inhibition alleviates postinjury neointimal formation and vascular restenosis.J Transl Med2026https://conductscience.org/library/papers/41634764PubMed
40843286Evaluation of a Targeted Drug-Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model.Adv Nanobiomed Res2021https://conductscience.org/library/papers/40843286PubMed
40442906Type IV Collagen-Targeting Nanoparticles for Efficient Delivery to the Renal Interstitium in Fibrotic Kidneys.Curr Drug Deliv2026https://conductscience.org/library/papers/40442906PubMed
40143044Oral Bioavailability Enhancement of Anti-Cancer Drugs Through Lipid Polymer Hybrid Nanoparticles.Pharmaceutics2025https://conductscience.org/library/papers/40143044PubMed
39587209Orally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery.Sci Rep2024https://conductscience.org/library/papers/39587209PubMed
39439489Deformable nanocarriers for enhanced drug delivery and cancer therapy.Exploration (Beijing)2024https://conductscience.org/library/papers/39439489PubMed
38930939Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis.Molecules2024https://conductscience.org/library/papers/38930939PubMed
38525311Simultaneous fingerprinting of multiplex collagen biomarkers in connective tissues by multicolor quantum dots-based peptide probes.Mater Today Bio2024https://conductscience.org/library/papers/38525311PubMed
37404681Atherosclerosis treatment with nanoagent: potential targets, stimulus signals and drug delivery mechanisms.Front Bioeng Biotechnol2023https://conductscience.org/library/papers/37404681PubMed
37063777Nanocarriers of shRNA-Runx2 directed to collagen IV as a nanotherapeutic system to target calcific aortic valve disease.Mater Today Bio2023https://conductscience.org/library/papers/37063777PubMed
37033603Lipid-engineered nanotherapeutics for cancer management.Front Pharmacol2023https://conductscience.org/library/papers/37033603PubMed
36733971Multifunctional nanoparticle-VEGF modification for tissue-engineered vascular graft to promote sustained anti-thrombosis and rapid endothelialization.Front Bioeng Biotechnol2023https://conductscience.org/library/papers/36733971PubMed
35851660Recent advancements in enzyme-incorporated nanomaterials: Synthesis, mechanistic formation, and applications.Biotechnol Bioeng2022https://conductscience.org/library/papers/35851660PubMed
35356091Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies.J Tissue Eng2022https://conductscience.org/library/papers/35356091PubMed
34870408Targeting the Extracellular Matrix in Traumatic Brain Injury Increases Signal Generation from an Activity-Based Nanosensor.ACS Nano2021https://conductscience.org/library/papers/34870408PubMed
34867370Nanotechnology for Targeted Therapy of Atherosclerosis.Front Pharmacol2021https://conductscience.org/library/papers/34867370PubMed
34834231Liposomal Nanocarriers Designed for Sub-Endothelial Matrix Targeting under Vascular Flow Conditions.Pharmaceutics2021https://conductscience.org/library/papers/34834231PubMed
34616741Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities.Front Cell Dev Biol2021https://conductscience.org/library/papers/34616741PubMed

See all 92 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20133865

GET https://conductscience.org/api/papers/v1/20133865/references?page=2